{"id":7380,"date":"2022-07-04T23:16:56","date_gmt":"2022-07-04T23:16:56","guid":{"rendered":"https:\/\/jobelyn.com.ng\/ng\/?p=7380"},"modified":"2024-04-18T03:18:59","modified_gmt":"2024-04-18T03:18:59","slug":"jobelyn-clinicaltrial-gov-list-of-registered-studies","status":"publish","type":"post","link":"https:\/\/jobelyn.com.ng\/ng\/2022\/07\/04\/jobelyn-clinicaltrial-gov-list-of-registered-studies\/","title":{"rendered":"Jobelyn ClinicalTrial. gov List of Registered STUDIES"},"content":{"rendered":"

 <\/p>\n

\n
\n

Quality of Life Study for Sickle Cell Patients Treated With\u00a0Jobelyn<\/span>\u00a0(Sorghum Bicolor Extract)<\/a><\/h3>\n
\n
NCT01704794<\/div>\n<\/div>\n
\n
\n

https:\/\/clinicaltrials.gov\/show\/NCT01704794,\u00a02012<\/strong>\u00a0| added to CENTRAL: 31 May 2018 | 2018 Issue 5<\/p>\n

CT.govkn<\/span><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
THE SHORT TIME EFFECT OF EXTRACT OF SORGHUM BICOLOR (JOBELYN) ON SICKLE CELL ANEMIA<\/a><\/div>\n
<\/div>\n
\n
<\/div>\n<\/div>\n
\n
\n
\n

Efficacy of\u00a0Jobelyn<\/span>\u2122 Consumption on Hemoglobin Levels in a Borderline Anemic Population<\/a><\/h3>\n
\n
NCT01828060<\/div>\n<\/div>\n
\n
\n

https:\/\/clinicaltrials.gov\/show\/NCT01828060,\u00a02013<\/strong>\u00a0| added to CENTRAL: 31 May 2018 | 2018 Issue 5<\/p>\n

CT.govEvaluation of the effects of Jobelyn\u2122 consumption on red blood cell count and quality<\/a><\/span><\/div>\n<\/div>\n
Evaluation of the effects of Jobelyn\u2122 consumption on red blood cell count and quality<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n
\n
\n
\n

The Safety and Efficacy of\u00a0Jobelyn<\/span>\u00a0in the Treatment of Breast Cancer Patients<\/a><\/h3>\n
\n
NCT01936064<\/div>\n<\/div>\n
\n
\n

https:\/\/clinicaltrials.gov\/show\/NCT01936064,\u00a02013<\/strong>\u00a0| added to CENTRAL: 31 May 2018 | 2018 Issue 5<\/p>\n

CT.gov<\/span><\/div>\n
Evaluation of the effects of Jobelyn\u2122 consumption on red blood cell count and quality<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
\n
\n
\n

The Safety and Effectiveness of\u00a0Jobelyn<\/span>\u00a0in Pre-operative Management of Anaemia in Gynaecological Patients<\/a><\/h3>\n
\n
NCT01670955<\/div>\n<\/div>\n
\n
\n

,\u00a02012<\/strong> | added to CENTRAL: 30 April 2015 |<\/p>\n<\/div>\n

\n
An open-label, randomized, parallel-group comparative study of the efficacy of sorghum bicolor extract in preoperative anemia (1)<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
\n
\n
\n

The Efficacy of\u00a0Jobelyn<\/span>\u00a0(Sorghum Bicolor Extract)in the Treatment of Sickle Cell Anemia<\/a><\/h3>\n
\n
NCT01703104<\/div>\n<\/div>\n
\n
\n

https:\/\/clinicaltrials.gov\/show\/NCT01703104,\u00a02012<\/strong>\u00a0| added to CENTRAL: 31 May 2018 | 2018 Issue 5<\/p>\n

CT.gov<\/span><\/div>\n
victory all<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
\n
\n
\n

Antipsychotic Effects of Sorghum Bicolor (JOBELYN<\/span>) in the Treatment of Schizophrenia<\/a><\/h3>\n
\n
NCT02240173<\/div>\n<\/div>\n
\n
\n

https:\/\/clinicaltrials.gov\/show\/NCT02240173,\u00a02014<\/strong>\u00a0| added to CENTRAL: 31 May 2018 | 2018 Issue 5<\/p>\n

CT.gov<\/span><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
\n
\n